You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

capmatinib

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC Trial in Pittsburgh (Capmatinib)

Not yet recruiting
  • Non-small Cell Lung Cancer
  • Capmatinib
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Jan 9, 2023

Oesophageal Adenocarcinoma, Gastric Adenocarcinoma Trial in France (Capmatinib, Spartalizumab)

Suspended
  • Oesophageal Adenocarcinoma
  • Gastric Adenocarcinoma
  • Besançon, France
  • +6 more
Feb 1, 2023

Metastatic NSCLC MET Exon 14 Skipping Mutation and Brain

Completed
  • Metastatic Non-Small Cell Lung Cancer
  • Capmatinib
  • East Hanover, New Jersey
    18 Novartis Investigative Sites in the US
Dec 29, 2022

Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer Trial in San Francisco (Capmatinib, Trametinib)

Recruiting
  • Metastatic Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer
  • San Francisco, California
    University of California San Francisco
Aug 15, 2022

NSCLC Trial in Japan, Korea, Republic of, Singapore (capmatinib, pemetrexed, cisplatin)

Terminated
  • Carcinoma, Non-Small-Cell Lung
  • capmatinib
  • +4 more
  • Kashiwa, Chiba, Japan
  • +3 more
Jan 31, 2023

Metastatic Breast Cancer, Breast Cancer Trial in Houston (Neratinib, Capmatinib)

Not yet recruiting
  • Metastatic Breast Cancer
  • Breast Cancer
  • Houston, Texas
    M D Anderson Cancer Center
Feb 16, 2022

NSCLC Trial in United States (capmatinib)

Recruiting
  • Non-small Cell Lung Cancer
  • capmatinib
  • La Jolla, California
  • +7 more
Oct 5, 2022

Advanced Solid Tumors Which Are cMET-dependent Trial in Worldwide (Capmatinib, Nazartinib, Gefitinib)

Recruiting
  • Advanced Solid Tumors Which Are cMET-dependent
  • Capmatinib
  • +3 more
  • Boston, Massachusetts
  • +12 more
Jan 27, 2023

NSCLC Trial in Worldwide (Capmatinib, Spartalizumab, Docetaxel)

Completed
Has Results
  • Carcinoma, Non-Small-Cell Lung
  • Capmatinib
  • +2 more
  • Fayetteville, Arkansas
  • +7 more
Jan 21, 2022

Carcinoma, Non-Small Cell Lung, NSCLC, Non-Small-Cell Lung Carcinoma Trial (Capmatinib)

Available
  • Carcinoma, Non-Small Cell Lung
  • +3 more
  • Capmatinib
  • (no location specified)
Aug 31, 2021

NSCLC (NSCLC) Trial in China (Capmatinib)

Recruiting
  • Non-Small Cell Lung Cancer (NSCLC)
  • Capmatinib
  • Xiamen, Fujian, China
  • +18 more
Jan 27, 2023

Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)

Not yet recruiting
  • Recurrent Lung Non-Small Cell Carcinoma
  • Stage IV Lung Cancer AJCC v8
  • Biospecimen Collection
  • +5 more
  • (no location specified)
Nov 30, 2022

NSCLC Trial in Worldwide (Capmatinib, Amivantamab)

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • Orange, California
  • +40 more
Aug 3, 2022

Non Small Cell Lung Cancer Trial in Worldwide (Capmatinib, Nazartinib)

Terminated
  • Non Small Cell Lung Cancer
  • Boston, Massachusetts
  • +18 more
Jul 20, 2022

Soft Tissue Sarcoma Trial in France (drug, combination product, other)

Recruiting
  • Soft Tissue Sarcoma
  • Bordeaux, France
  • +17 more
Oct 4, 2022

ALK Fusion Protein Expression, BRAF wt Allele, Invasive Skin Melanoma Trial in San Francisco (Capmatinib, Ceritinib,

Terminated
Has Results
  • ALK Fusion Protein Expression
  • +14 more
  • Capmatinib
  • +4 more
  • San Francisco, California
    University of California, San Francisco
Jan 14, 2020

Cancer, Lung Cancer Metastatic, MET Gene Mutation Trial in Seoul (Capmatinib)

Unknown status
  • Cancer
  • +2 more
  • Capmatinib
  • Seoul, Korea, Republic of
    Asan Medical Center
Oct 1, 2018